Tuberculosis associated with therapy against tumor necrosis factor alpha - PubMed (original) (raw)

Review

. 2005 Oct;52(10):2968-74.

doi: 10.1002/art.21382.

Affiliations

• PMID: 16200576
• DOI: 10.1002/art.21382

Free article

Review

Tuberculosis associated with therapy against tumor necrosis factor alpha

Kevin L Winthrop et al. Arthritis Rheum. 2005 Oct.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Infection and anti-tumor necrosis factor-alpha therapy.
  Zandman-Goddard G. Zandman-Goddard G. Isr Med Assoc J. 2003 Nov;5(11):814-6. Isr Med Assoc J. 2003. PMID: 14650109 Review. No abstract available.
• Tumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk.
  Khasnis AA, Calabrese LH. Khasnis AA, et al. Semin Arthritis Rheum. 2010 Oct;40(2):147-63. doi: 10.1016/j.semarthrit.2009.09.001. Epub 2009 Nov 14. Semin Arthritis Rheum. 2010. PMID: 19914686 Review.
• Making tumor necrosis factor blockers safer: a prescriber's consumptive challenge.
  Keane J, Ní Cheallaigh C. Keane J, et al. J Rheumatol. 2008 Jul;35(7):1238-9. Epub 2008 Jun 15. J Rheumatol. 2008. PMID: 18597413 No abstract available.
• Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?
  Winger EE, Reed JL. Winger EE, et al. J Rheumatol. 2009 Sep;36(9):2122; author reply 2123. doi: 10.3899/jrheum.090141. J Rheumatol. 2009. PMID: 19738224 No abstract available.

Cited by

• Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces soluble tumor necrosis factor receptor production through tumor necrosis factor alpha-converting enzyme activation.
  Richmond JM, Duffy ER, Lee J, Kaboli K, Kim YS, Remick DG, Kornfeld H, Cruikshank WW. Richmond JM, et al. Infect Immun. 2012 Nov;80(11):3858-68. doi: 10.1128/IAI.00060-12. Epub 2012 Aug 27. Infect Immun. 2012. PMID: 22927046 Free PMC article.
• Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation.
  Liang H, Peng B, Dong C, Liu L, Mao J, Wei S, Wang X, Xu H, Shen J, Mao HQ, Gao X, Leong KW, Chen Y. Liang H, et al. Nat Commun. 2018 Oct 16;9(1):4291. doi: 10.1038/s41467-018-06603-5. Nat Commun. 2018. PMID: 30327464 Free PMC article.
• Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
  Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D; RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group. Hamdi H, et al. Arthritis Res Ther. 2006;8(4):R114. doi: 10.1186/ar1994. Arthritis Res Ther. 2006. PMID: 16859506 Free PMC article.
• Rare Complication During Anti-TNF-α Treatment in a Patient with Crohn's Disease: A Case Report and Review of the Literature.
  Statie RC, Florescu DN, Gheonea DI, Ciurea T. Statie RC, et al. Curr Health Sci J. 2021 Jan-Mar;47(1):132-138. doi: 10.12865/CHSJ.47.01.22. Epub 2021 Mar 31. Curr Health Sci J. 2021. PMID: 34211761 Free PMC article.
• Marine-Derived Biologically Active Compounds for the Potential Treatment of Rheumatoid Arthritis.
  Bilal M, Qindeel M, Nunes LV, Duarte MTS, Ferreira LFR, Soriano RN, Iqbal HMN. Bilal M, et al. Mar Drugs. 2020 Dec 29;19(1):10. doi: 10.3390/md19010010. Mar Drugs. 2020. PMID: 33383638 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley